https://www.goodrx.com/conditions/urinary-tract-infection/gepotidacin-fda-approval
FDA Approves Gepotidacin for UTI Treatment for Women - GoodRx
The FDA approved gepotidacin, a first-in-class UTI antibiotic for adolescent and adult women. Learn how gepotidacin works, when it will be available, and more.
uti treatmentfdaapprovesgepotidacinwomen
https://pmc.ncbi.nlm.nih.gov/articles/PMC13061509/
Genetic background modulates zoliflodacin and gepotidacin cross-resistance and fitness in Neisseria...
The emergence of multi-drug-resistant Neisseria gonorrhoeae has created an urgent need for new therapeutic options. Zoliflodacin and gepotidacin, two...
genetic backgroundcross resistancezoliflodacin
https://www.gsk.com/en-gb/media/press-releases/gsk-starts-a-phase-iii-clinical-programme-for-a-potential-first-in-class-antibiotic-gepotidacin/
GSK starts a phase III clinical programme for a potential first-in-class antibiotic, gepotidacin |...
First in a new chemical class of antibiotic with a mechanism of action distinct from any currently approved antibiotic.
https://www.goodrx.com/blujepa/gepotidacin-for-uti
Blujepa (Gepotidacin) for UTIs: How to Maximize Its Effectiveness - GoodRx
Blujepa is the first antibiotic in its class FDA approved for UTI treatment. Learn more with these tips to maximize the effectiveness of gepotidacin for UTIs.
how toblujepagepotidacinutismaximize
https://www.gsk.com/en-gb/media/press-releases/gepotidacin-accepted-for-priority-review-by-us-fda-for-treatment-of-uncomplicated-urinary-tract-infections-in-female-adults-and-adolescents
Gepotidacin accepted for priority review by US FDA for treatment of uncomplicated urinary tract...
Gepotidacin could be the first in a new class of oral antibiotic treatment for uUTIs in over 20 years.
https://www.cigna.com/knowledge-center/hw/medications/gepotidacin-a625059
Gepotidacin | Cigna
Gepotidacin is used to treat urinary tract infections (UTIs). Gepotidacin is in a class of medications called antibiotics. It works by killing bacteria. This...
gepotidacincigna
https://pmc.ncbi.nlm.nih.gov/articles/PMC6927889/
In vitro activity of the novel triazaacenaphthylene gepotidacin (GSK2140944) against MDR Neisseria...
Increased antimicrobial resistance surveillance and new effective antimicrobials are crucial to maintain treatable gonorrhoea. We examined the in vitro...
in vitroof the
https://www.gsk.com/en-gb/media/press-releases/gepotidacin-accepted-for-priority-review-by-the-us-fda-for-the-oral-treatment-of-uncomplicated-urogenital-gonorrhoea/
Gepotidacin accepted for priority review by the US FDA for the oral treatment of uncomplicated...
Submission supported by positive phase III data in patients with uncomplicated urogenital gonorrhoea in EAGLE 1 trial
https://www.gsk.com/en-gb/media/press-releases/gsk-announces-phase-iii-trials-for-gepotidacin/
EAGLE-2 and EAGLE-3 phase III trials for gepotidacin stopped early for efficacy following...
Gepotidacin could be the first new novel oral antibiotic treatment for uncomplicated urinary tract infections in over 20 years
2 and 3phase iii trials
https://pmc.ncbi.nlm.nih.gov/articles/PMC9589544/
Design of Two Phase III, Randomized, Multicenter Studies Comparing Gepotidacin with Nitrofurantoin...
Uncomplicated urinary tract infections (uUTIs) are among the most common community-acquired infections for women worldwide. Treatment options are increasingly...
design oftwo phase
https://www.gsk.com/en-gb/media/press-releases/blujepa-gepotidacin-approved-by-us-fda-as-oral-option-for-treatment-of-uncomplicated-urogenital-gonorrhoea-ugc/
Blujepa (gepotidacin) approved by US FDA as oral option for treatment of uncomplicated urogenital...
Blujepa is the first in a new antibiotic class for the treatment of gonorrhoea approved in over three decades.
https://blujepahcp.com/
Uncomplicated UTI Treatment | BLUJEPA (gepotidacin)
Discover BLUJEPA, a first-in-class antibiotic treatment for patients with uncomplicated urinary tract infections.
uncomplicated utitreatmentblujepagepotidacin